1. The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient 
P. Friederich, H. Pfizenmayer 
British Journal of Anaesthesia 
Volume 107, Issue 4, Pages (October 2011)
DOI: /bja/aer278
Copyright © 2011 The Author(s) Terms and Conditions

2. Fig 1
Time course of heart rate (HR, beats min−1) before, during treatment with vernakalant (target dose 3 mg kg−1 within 10 min), and after treatment with vernakalant (total dose 204 mg, 2.9 mg kg−1 within 11 min).
British Journal of Anaesthesia  , DOI: ( /bja/aer278)
Copyright © 2011 The Author(s) Terms and Conditions